Sep 20 to 23, 2021 Booth # 874
With customers around the world and expertise in all aspects of RNAi technology, we are ambitious, grow fast, and are committed to providing the best siRNA drug development services. We have an impeccable track record of helping customers with siRNA drug design and in vivo delivery.
Utilizing the latest nucleic acid synthesis technology to provide customized siRNA oligonucleotide synthesis services, suitable for a variety of labeling, modification, scale, and purity.
The chemical synthesis of DNA/RNA has become a very useful method in current laboratory practice because it can quickly and cheaply access custom oligonucleotides of the desired sequence.
Oligo can be used for targeted gene therapy. It’s necessary to analyze and purify the oligo after synthesis to get high purity products for drug discovery or biomedical research.
As an RNAi effector molecule, siRNA regulates the expression of eukaryotic genes at the most important level of genomic function, including chromatin structure, RNA processing/stabilization...
The drug delivery system has become an effective tool for transporting drug candidates in vivo. It can not only provide drug stability but also be targeted.
BOC RNA is a sub-brand of BOC Sciences, which mainly focuses on RNA technology and its broad prospects in disease treatment.
We provide comprehensive RNA related products and services, including siRNA design, synthesis, analysis, coupling, and delivery and mRNA vaccines, covering all development processes of RNA drugs.
We will make every effort to help simplify and accelerate your drug discovery and disease treatment research efforts.
We collaborate with Shiyue Fang’s group from Michigan Technological University on sensitive DNA/RNA synthesis.
Science Advisor: Prof Shiyue Fang